Abstract
This article reviews the currently available data on the role of peroxisomal function in relation to the processes of cell differentiation and carcinogenesis. In regard to tumourigenesis, both genotoxic and non-genotoxic processes have been considered, and the peroxisomal relationships with these phenomena and with differentiation are described at the level of organelle characteristics, enzyme contents, and the involvement of retinoids, steroid hormones, oxygen free radicals, growth factors, apoptosis, omega-3 polyunsaturated fatty acids and the cellular signalling networks. Overall these data serve to illustrate the unique and distinctive role of the peroxisome in differentiation and carcinogenesis, and point to the advantages of considering the peroxisomal involvement in the holistic context of the differentiation dedifferentiation continuum rather than the narrower focus of non-genotoxic carcinogenesis. The review also outlines the potential for medical benefit arising from a fuller understanding of these peroxisomal affiliations.
Similar content being viewed by others
References
Harris CC: Chemical and physical carcinogenesis: Advances and perspectives for the 1990's. Cancer Res 51(Suppl): 5023S-5044S, 1991
Ames BN, Gold LS, Willett WC: The causes and prevention of cancer. Proc Natl Acad Sci 92: 5258-5265, 1995
Masters CJ, Holmes RS: Haemoglobin, isoenzymes and tissue differentiation, North Holland. Frontiers of Biology Series, Amsterdam, 1975
Reddy JK, Azarnoff DL, Highnite CE: Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 283: 397-398, 1980
Masters CJ, Crane DI: On the role of the peroxisome in ontogeny, ageing and degenerative disease. Mech Ageing Devel 80: 69-83, 1995
Lake BG: Peroxisome proliferation: Current mechanisms relating to nongenotoxic carcinogenesis. Toxicol Lett 82-3: 673-681, 1995
Masters C, Crane D: The Peroxisome - A Vital Organelle. Cambridge University Press, Cambridge, 1995
de Duve C: Microbodies in the living cell. Sci Am 248: 52-62, 1983
van den Bosch H, Schutgens RBH, Wanders RJA, Tager JM: Biochemistry of peroxisomes. Ann Rev Biochem 61: 157-197, 1992
Roels F: Peroxisomes. VUB Press, Brussels, 1991
Moser HW: In: H. Harris, K. Hirschhorn (eds). Peroxisomal Disorders and Advances in Human Genetics. Vol. 21. Plenum, New York, 1993, pp 1-106
Masters C, Holmes R: Peroxisomes, new aspects of cell physiology and biochemistry. Physiol Rev 57: 816-882, 1977
Keller JM, Cable S, Elbouhtory F, Heusser S, Scotto C, Armbruster L, Ciolek E, Colin S, Schilt J: Peroxisomes through cell differentiation and neoplasia. Biol Cell 77: 77-88, 1993
Peterson SL, Stevenson PM: Changes in catalase activity and concentration during ovarian development and differentiation. Biochem Biophys Acta 1135: 207-214, 1992
Van den Branden C, Dacremont G, Hoogh R, Roels F: Inhibition of peroxisomal β-oxidation and brain development in rats. Glia 2: 260-265, 1989
Lazo O, Singh AK, Singh I: Postnatal development and isolation of peroxisomes from brain. J Neurochem 56: 1343-1353, 1991
Mangelsdorf DJ, Kliewer SA, Kakizuke A, Umesono K, Evans RM: Retinoid receptors. Recent Prog Horm Res 48: 99-121, 1993
Beier K, Volkl A, Fahimi HD: The impact of aging on enzyme proteins of rat liver peroxisomes: Quantitative analysis by immunoblotting and immunoelectron microscopy. Virchows Arch B Cell Pathol 63: 139-146, 1993
Perichon R, Bourre JM: Liver peroxisomal fatty acid oxidizing system during aging in control and clofibrate-treated mice. Biochem Mol Biol Int 37: 475-480, 1995
Greenstein JP, Jenrette WV, White J: The liver catalase activity of tumour-bearing rats and the effect of extirpation of the tumours. J Natl Cancer Inst 2: 283-291, 1941
Greenstein JP: Biochemistry of Cancer. Academic Press, New York, 1947, pp 325-330
Nishimura ET, Kobara TY, Kaltenbach JP, Wartman WB: Immunological evidence of repressed catalase synthesis in livers of tumour-bearing mice. Arch Biochem Biophys 97: 589-595, 1962
Rabilloud T, Asselineau D, Miguel C, Calvayrac R, Darmon M, Vuillaume M: Deficiency in catalase activity correlates with the appearance of tumour phenotype in human keratinocytes. Int J Cancer 45: 952-956, 1990
Kampschmidt RF: Mechanism of liver catalase depression in tumourbearing animals: A review. Cancer Res 25: 34-45, 1964
Green S: Receptor mediated mechanisms of peroxisome proliferators. Biochem Pharmacol 43: 393-401, 1992
Green S, Tugwood JD, Isseman I: The molecular mechanism of peroxisome proliferator action: A model for species differences and mechanistic risk assessment. Toxicol Lett 131-9: 64-65, 1992
Masters C, Crane D: Recent developments in peroxisome biology. Endeavour 20: 68-73, 1996
Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W: Control of the peroxisomal β oxidation pathway by a novel family of nuclear hormone receptors. Cell 68: 879-887, 1992
Desvergme B, Wahli W: PPAR: A key nuclear factor in nutrient/gene interactions. In: P. Baeurle (ed). Progress in Gene Expression. Vol. 1. Birkhaüser, Boston, 1994, pp 142-176
Kliewer SA, Forman BM, Ong ES, Borgmeyer V, Mangelsdorf DJ, Umesono K, Evans RM: Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91: 7355-7359, 1994
Bojes HK, Thurman RG: Peroxisomal proliferators inhibit acyl CoA synthetase and stimulate protein kinase C in vivo. Toxicol Appl Pharmacol 126: 233-239, 1994
Wahli W, Braissant O, Desvergne B: Peroxisome proliferator activated receptors: Transcriptional regulators of adipogenesis, lipid metabolism and more... Chemistry and Biology 2: 261-266, 1995
Evans RM: The steroid and thyroid hormones receptor superfamily science 240: 889-895, 1988
Van Poppel G: Carotenoids and cancer: An update with emphasis on human intervention studies. Eur J Cancer 29A: 1335-1344, 1993
Moon MK, Mehta M: Chemoprevention of mammary cancer by retinoids. Basic Life Sci 52: 213-224, 1990
Chawla A, Lazar MA: Peroxisome proliferator and retinoid signaling pathways coregulate preadipocyte phenotype and survival. Proc Natl Acad Sci USA 91: 1786-1790, 1994
Stunnenberg HG: Mechanisms of transactivation by retinoic acid receptors. Bioessays 15: 309-315, 1993
Sher T, Yi H-F, McBride OW, Gonzalez FJ: CDNA cloning chromosomal mapping and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32: 5598-5604, 1993
Crane DI, Masters CJ: Alterations in the integrity of peroxisomal membranes in livers of mice treated with peroxisome proliferators. Mol Cell Biochem 96: 153-161, 1990
Vineis P, Brandt-Rauf PW: Mechanisms of carcinogenesis: Chemical exposure and molecular changes. Eur J Biochem 29A: 1344-1347, 1993
Miyashita T, Reed JC: Tumour suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299, 1995
Hunter T: Braking the cycle cell 75: 839-841, 1993
Rao MS, Yeldandi AV, Subbarao V, Reddy JK: Evidence that ciprofibrate, a potent peroxisome proliferator is a complete carcinogen in the rat. Proc Am Assoc Cancer Res 31: 86, 1990
Rao MS, Reddy JK: An overview of peroxisome proliferator-induced hepatocarcinogenesis. Environ Health Perspect 93: 205-209, 1991
Yokoyama Y, Tsuchida S, Hatayama I, Sato K: Lack of peroxisomal enzyme inducibility in rat hepatic preeoplastic lesions induced by mutagenic carcinogens: Contrasted expression of glutathione Stransferase P form and enoyl CoA hydratase carcinogenesis 14: 393-398, 1993
Dhaunsi GS, Singh I, Orak JK, Singh AK: Antioxidant enzymes in ciprofibrate-induced oxidative stress. Carcinogenesis 15: 1923-1930, 1994
Orellana A, Holoigue L, Hidalgo PC, Faundez V, Gonzalez A, Bronfman M: Ciprofibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of epidermal growth factor receptor in isolated rat hepatocytes. Eur J Biochem 215: 903-906, 1993
Ames BN, Shigenaga MK, Hagen TM: Oxidants, antioxidants and the degenerative diseases of ageing. Proc Natl Acad Sci USA 90: 7915-7922, 1993
Moody DE, Reddy JK, Lake BG, Popp JA, Reese DH: Peroxisome proliferation and non-genotoxic carcinogenesis - commentary on a symposium. Fund Appl Toxicol 16(2): 233-248, 1991
Clayson DB, Mehta R, Iverson F: Oxidative DNA damage - the effects of certain genotoxic and operationally non-genotoxic carcinogens. Mutat Res 317: 25-42, 1994
Rao MS, Lalwani ND, Watanabe TK, Reddy JK: Inhibitory effects of anitoxidants ethoxyquin and 2(3)-tert-buty-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator. Cancer Res 44: 1072-1076, 1984
Chance B, Sies H, Boveris A: Hydroperoxide metabolism in mammalian organs. Physiol Rev 59: 527-605, 1979
Janssen YMW, Houten B, Borm PJA, Mossmann BT: Cell and tissue responses to oxidative damage. Lab Invest 69: 261-271, 1993
Sun Y: Free radicals, antioxidant enzymens and carcinogenesis. Free Rad Biol Med 8: 583-599, 1990
Takagi A, Sai K, Umemura T, Hasegawa R, Kurokawa Y: Relationship between hepatic peroxisome proliferation and 8-hydroxydeoxyquanosine formation in liver DNA of rats following long term exposure to three peroxisome proliferators. Cancer Lett 53: 33-38, 1990
Cattley RC, Glover SE: Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: Relationship to carcinogenesis and nuclear localisation carcinogenesis 14: 2495-2499, 1993
Ames BN, Gold LS: Too many rodent carcinogens: Mitogenesis increases mutagenesis. Science 249: 970-971, 1990
Grisham JW, Kaufman WK, Kaufman DG: The cell cycle and carcinogenesis. Surv Synth Pathol Res 1: 49-66, 1983
Lehninger AL, Nelson DL, Cox MM: Principles of Biochemistry, 2nd edn. Worth Publishers, New York, 1992
Hegi ME, Fox TR, Belinsky SA, Devereux TR, Anderson MA: Analysis of activated protooncogenes in B6C3F1 mouse liver tumours induced by ciprofibrate, a potent peroxisome proliferator. Carcinogenesis 14: 145-149, 1993
Hamilton GA: Oxalyl thiolesters, novel intermediates in biological systems. In: V.T. D'Souza, T. Feder (eds). The Bioorganic Chemistry of Enzymatic Analysis: An Homage to Myron L. Bender, CRC Press, Ann Arbor, 1991, pp 79-89
Hamilton GA: Peroxisomal oxidases and suggestions for the mechanism of action of insulin and other hormones. Adv Enzymol 57: 85-178, 1985
Masters C: Cellular signalling: The role of the peroxisome Cell. Signalling 8: 197-208, 1996
Borek C: ω-3 Fatty acids as an anticarcinogens: Cellular and molecular studies. In: C. Galli, A.P. Simopoulos, E. Tremoli (eds). Effects of Fatty Acids and Lipids in Health and Disease. Vol. 76, Karger, Basel, 1994, pp 66-69
Masters C: Omega-3 fatty acids and the peroxisome. Mol Cell Biochem 165: 83-93, 1996
Lake BG: Mechanisms of hepatocarcinogenility of peroxisome proliferating drugs and chemicals. Ann Rev Pharmacol Toxicol 35: 483-507, 1995
Bayly AL, Roberts RA, Dive C: Suppression of liver cell apoptosis in vitro by the nongenotoxic hepatocarcinogen and peroxisome proliferator nafenopin. Cell Biol 125: 197-203, 1994
Bayly AC, French NJ, Dive C, Roberts RA: Non genotoxic hepatocarcinogenesis in vitro: The FaO hepatoma line responds to peroxisome proliferators and retains the ability to undergo apoptosis. J Cell Sci 104: 307-315, 1993
Kashiwagi A: Peroxisomal enzyme activity changes in the tail of Anuran tadpoles during metamorphosis. Comp Biochem Physiol B Biochem Mol Biol III: 483-489, 1995
Claria J, Serhan EN: Aspirin triggers previously underscribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 92: 9475-9482, 1995
Masters C: On the role of the peroxisome in the metabolism of drugs and xenobiotics. Biochem Pharmacol (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Masters, C., Crane, D. On the role of the peroxisome in cell differentiation and carcinogenesis. Mol Cell Biochem 187, 85–97 (1998). https://doi.org/10.1023/A:1006863123068
Issue Date:
DOI: https://doi.org/10.1023/A:1006863123068